A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
2014 · Biological Psychiatry · 474 citations
https://doi.org/10.1016/j.biopsych.2014.03.026
K
Kyle Lapidus
Laidlaw College(NZ)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
5.8K
Citations
25
h-index
32
i10-index
Kyle Lapidus is an academic researcher from Laidlaw College. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Obsessive-Compulsive Spectrum Disorders. The author has an h-index of 25, co-authored 53 publications.
Papers by this author
worksEfficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial
2019 · American Journal of Psychiatry · 405 citations
https://doi.org/10.1176/appi.ajp.2019.18101180
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
2015 · Psychological Medicine · 291 citations
https://doi.org/10.1017/s0033291715001506
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
2015 · The International Journal of Neuropsychopharmacology · 226 citations
https://doi.org/10.1093/ijnp/pyv124
Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy
2016 · Journal of Psychiatry and Neuroscience · 152 citations
https://doi.org/10.1503/jpn.150223
In vivo 1H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder
2014 · Neuroscience Letters · 68 citations
https://doi.org/10.1016/j.neulet.2014.03.056
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat